Dr. Randall Harrell (MD) is the Founder, Chairman, and CEO of Regenerative Processing Plant, LLC. He has worked for over 30 years to become a pioneer and visionary in regenerative medicine, where his discoveries and patented platform technologies in the study of Type III human collagen, stem cells, and pericytes have led to many developments and therapies.
 
The result of his work is Regener-Eyes® (generic name “derived-Multiple Allogeneic
Proteins Paracrine Signaling [d-MAPPS]”), an ophthalmic solution that contains a large
number of immunoregulatory factors that are capable of penetrating the ocular surface and
to efficiently attenuate the detrimental immune response in the eye, promoting the repair and regeneration of injured tissue.

Regener-Eyes® is known to reverse dry eye. However, due to its regenerative and anti-inflammatory attributes, it is the eye drop of choice for:
 

• Dry Eyes,

• Cataracts (in combination with Can-C drops)

• Macular Degeneration, and

• Glaucoma

​
This is a pioneering area of development. Although unproven in glaucoma and macular degeneration, it is worth trying for those suffering from these conditions.